Locations

ZURICH

Private financing in ZURICH, aggregated from public sources.

$32.2M
Capital raised
5
Companies
12
Rounds
2019
First on record
2025-06-27
Latest round

Cooling ZURICH drew — over the last 12 months, down 100% versus the prior 12 ($10.7M). Of 5 companies rankable against same-niche peers, 0% model over-valued and 40% under-valued.

Capital flow over time

Quarterly capital raised in ZURICH.

2019-Q1 · $300K2019-Q12019-Q2 · $148K2019-Q22021-Q1 · $500K2021-Q12022-Q1 · $4.0M2022-Q12022-Q4 · $14.0M2022-Q42024-Q1 · $1.8M2024-Q12024-Q2 · $787K2024-Q22024-Q4 · $7.2M2024-Q42025-Q1 · $2.5M2025-Q12025-Q2 · $1.0M2025-Q2
Sector mix
SectorCompaniesRoundsCapital
Pharmaceuticals18$27.2M
Other Technology33$4.5M
Other Travel11$500K
Top-funded companies
CompanySectorRaisedModeled value
Experify Inc.Other Technology$4.0M$59.9M
Procivis AGOther Technology$300K$12.7M
Doofus CorpOther Technology$148K$6.3M
Flavor Network Holdings, Inc.Other Travel$500K$3.6M
NLS Pharmaceutics Ltd.Pharmaceuticals$27.2M$3.3M
Other locations
SAN FRANCISCO$186.3BNEW YORK$184.6BBOSTON$44.5BNew York$39.7BAUSTIN$29.3BCHICAGO$28.9BLOS ANGELES$27.7BCAMBRIDGE$24.7B

Browse all locations or the full company rankings.

Frequently asked
How much venture funding have companies in ZURICH raised?
Companies based in ZURICH have raised approximately $32.2M across 12 recorded financing rounds among 5 companies, aggregated from public sources.
Is startup funding in ZURICH growing?
ZURICH funding is currently cooling: capital raised over the last 12 months was down 100% versus the prior 12 months.
What sectors are most active in ZURICH?
The most active sectors in ZURICH by recorded financing are Pharmaceuticals, Other Technology, Other Travel. See the sector mix table for company and round counts.
Which are the most-funded companies in ZURICH?
The most-funded ZURICH companies in our coverage include Experify Inc., Procivis AG, Doofus Corp, Flavor Network Holdings, Inc., NLS Pharmaceutics Ltd.. See the ranked table for disclosed capital and modeled valuations.